On May 19, 2022, Scandinavian Tobacco Group A/S announced that its stock buyback program, which began on March 9, 2022, has been increased to a total value of up to 1 billion Danish kroner. The purpose of the program is to adjust the company's capital structure and fulfill obligations related to the group's equity incentive plan.
Some of the share buyback program was executed based on the Market Abuse Regulation (MAR) on April 16, 2014, and on Commission Delegated Regulation (EU) 2016/1052, also known as the Safe Harbour Rules. The remaining portion of the stock buyback program was carried out as a directed buyback by Chr. Augustine Fabrikker Aktieselskab and CW Obel A/S, as described in company announcement no. 1/2022. The share buyback program will end no later than February 28, 2023.
The following transactions were executed from December 5th to December 9th, 2022.
The average purchase price of shares, the trading value of Danish kroner, and the cumulative value of Danish kroner were announced on December 9, 2022, totaling 81,346 shares purchased between December 5th and December 9th. On December 9th, shares were purchased from CAF and CWO, with a cumulative total of 5,053,326 shares purchased under the program. CAF participated in the stock buyback plan at a ratio of 27.0%, and CWO participated at a ratio of 12.5%, according to a separate agreement from May 20, 2022. On December 5th, shares were announced at a value of 15,264.541,946,714, increasing to 25,000 on December 6th and dropping to 22,500 on December 7th. On December 8th, the value of shares was 6,955, and on December 9th, it was 11,627, with a total value of 648,693,500 accumulated under the program.
This notice includes a detailed overview of transactions conducted during the period of December 5 to December 9, 2022.
2FIRSTS will continue to track and report on this issue. Further updates will be available on the "2FIRSTSAPP." Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
